155 related articles for article (PubMed ID: 18525120)
41. Effect of NELL1 on lung cancer stem‑like cell differentiation.
Zhai Y; Wei R; Sha S; Lin C; Wang H; Jiang X; Liu G
Oncol Rep; 2019 Mar; 41(3):1817-1826. PubMed ID: 30628703
[TBL] [Abstract][Full Text] [Related]
42. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.
Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y
Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250
[TBL] [Abstract][Full Text] [Related]
43. shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells.
Xu Y; Hu YD; Zhou J; Zhang MH; Yuan WW; Luo Y
Oncol Rep; 2012 Aug; 28(2):629-39. PubMed ID: 22664532
[TBL] [Abstract][Full Text] [Related]
44. [Advances in Lung Stem Cells and Lung Cancer Stem Cells].
Yin H; Deng J
Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):633-9. PubMed ID: 26483336
[TBL] [Abstract][Full Text] [Related]
45. Lung cancer stem cells-characteristics, phenotype.
Hardavella G; George R; Sethi T
Transl Lung Cancer Res; 2016 Jun; 5(3):272-9. PubMed ID: 27413709
[TBL] [Abstract][Full Text] [Related]
46. [Stem cells and cancer].
Arvelo F; Cotte C; Sojo F
Invest Clin; 2014 Dec; 55(4):371-91. PubMed ID: 25558756
[TBL] [Abstract][Full Text] [Related]
47. Cell of origin of lung cancer.
Sutherland KD; Berns A
Mol Oncol; 2010 Oct; 4(5):397-403. PubMed ID: 20594926
[TBL] [Abstract][Full Text] [Related]
48. Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
Ahmed N; Abubaker K; Findlay JK
Mol Aspects Med; 2014 Oct; 39():110-25. PubMed ID: 23811037
[TBL] [Abstract][Full Text] [Related]
49. Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages.
Xu Y; Xu Z; Li Q; Guo L; Wang Y; Zhou J; Wang G; Liu Y
J Immunol Res; 2019; 2019():7478538. PubMed ID: 31781681
[TBL] [Abstract][Full Text] [Related]
50. Can lung cancer stem cells be targeted for therapies?
Wu X; Chen H; Wang X
Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
[TBL] [Abstract][Full Text] [Related]
51. Lung cancer stem cells: tumor biology and clinical implications.
Nurwidya F; Murakami A; Takahashi F; Takahashi K
Asia Pac J Clin Oncol; 2012 Sep; 8(3):217-22. PubMed ID: 22897822
[TBL] [Abstract][Full Text] [Related]
52. Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells, but tumorigenicity does correlate with Wnt pathway activation.
Vaughan AE; Halbert CL; Wootton SK; Miller AD
Mol Cancer Res; 2012 Jan; 10(1):86-95. PubMed ID: 22064658
[TBL] [Abstract][Full Text] [Related]
53. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
Mirza S; Jain N; Rawal R
Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
[TBL] [Abstract][Full Text] [Related]
54. Reversal of cisplatin resistance in non-small cell lung cancer stem cells by Taxus chinensis var.
Jiang YQ; Xu XP; Guo QM; Xu XC; Liu QY; An SH; Xu JL; Su F; Tai JB
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706681
[TBL] [Abstract][Full Text] [Related]
55. [Lung adenocarcinoma stem cell phenotypes and their correlation with patient prognosis].
Zhang XY; Zheng BQ; Han BH; Huang JS; Geng Q; Xu HL; Zhou J; Dong QG
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):836-40. PubMed ID: 20137348
[TBL] [Abstract][Full Text] [Related]
56. [The fundamental mechanisms of metastatic spread and chemotherapy resistance in lung cancer].
Tomuleasa C; Kacso G; Soritau O; Susman S; Petrushev B; Aldea M; Buiga R; Irimie A
Pneumologia; 2011; 60(2):99-103. PubMed ID: 21823362
[TBL] [Abstract][Full Text] [Related]
57. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
[TBL] [Abstract][Full Text] [Related]
58. Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
Maiuthed A; Chantarawong W; Chanvorachote P
Anticancer Res; 2018 Jul; 38(7):3797-3809. PubMed ID: 29970499
[TBL] [Abstract][Full Text] [Related]
59. FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.
Ji W; Yu Y; Li Z; Wang G; Li F; Xia W; Lu S
Oncotarget; 2016 Mar; 7(12):15118-34. PubMed ID: 26936993
[TBL] [Abstract][Full Text] [Related]
60. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
